Výsledky vyhledávání - S. Piha-Paul
- Zobrazuji výsledky 1 - 20 z 249
- Přejít na další stránku
-
1
-
2
-
3
-
4
Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301... Autor Mukhtar, Eiman, Worroll, Daniel, Galletti, Giuseppe, Schuster, Shelly, Piha-Paul, Sarina A., Giannakakou, Paraskevi
Vydáno 2020Text -
5
-
6
Biomarker-Directed Therapy of Squamous Carcinomas of the Head and Neck: Targeting PI3K/PTEN/mTOR Pathway Autor Holsinger, Floyd Christopher, Piha-Paul, Sarina Anne, Janku, Filip, Hong, David S., Atkins, Johnique T., Tsimberidou, Apostolia M., Kurzrock, Razelle
Vydáno 2013Text -
7
A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies Autor Taylor, Matthew H., Alva, Ajjai S., Larson, Timothy, Szpakowski, Sebastian, Purkaystha, Das, Amin, Alpesh, Karpiak, Linda, Piha-Paul, Sarina A.
Vydáno 2020Text -
8
Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus Autor Piha-Paul, Sarina A., Shin, Sang Joon, Vats, Tribhawan, Guha-Thakurta, Nandita, Aaron, Joann, Rytting, Michael, Kleinerman, Eugenie, Kurzrock, Razelle
Vydáno 2014Text -
9
Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors Autor Mita, Monica, Fu, Siqing, Piha-Paul, Sarina Anne, Janku, Filip, Mita, Alain, Natale, Ronald, Guo, Wei, Zhao, Charles, Kurzrock, Razelle, Naing, Aung
Vydáno 2017Text -
10
-
11
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumors Autor Piha-Paul, S.A., Munster, P.N., Hollebecque, A., Argilés, G., Dajani, O., Cheng, J.D., Wang, R., Swift, A., Tosolini, A., Gupta., S.
Vydáno 2015Text -
12
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial Autor How, Jeffrey A., Jazaeri, Amir A., Soliman, Pamela T., Fleming, Nicole D., Gong, Jing, Piha-Paul, Sarina A., Janku, Filip, Stephen, Bettzy, Naing, Aung
Vydáno 2021Text -
13
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer Autor Funda Meric‐Bernstam, Amber M. Johnson, Ecaterina E. Dumbrava, Kanwal Raghav, Kavitha Balaji, Michelle Bhatt, Rashmi K. Murthy, Jordi Rodón, Sarina A. Piha‐Paul
Vydáno 2018Revisão -
14
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus Autor Piha-Paul, Sarina A., Wheler, Jennifer J., Fu, Siqing, Levenback, Charles, Lu, Karen, Falchook, Gerald S., Naing, Aung, Hong, David S., Tsimberidou, Apostolia M., Kurzrock, Razelle
Vydáno 2014Text -
15
Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience Autor Wheler, Jennifer, Tsimberidou, Apostolia M., Hong, David, Naing, Aung, Falchook, Gerald, Piha-Paul, Sarina, Fu, Siqing, Moulder, Stacy, Stephen, Bettzy, Wen, Sijin, Kurzrock, Razelle
Vydáno 2012Text -
16
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors Autor Durairaj, Chandrasekar, Chakrabarti, Jayeta, Ferrario, Cristiano, Hirte, Holger W., Babu, Sunil, Piha-Paul, Sarina A., Plotka, Anna, Hoffman, Justin, Shi, Haihong, Wang, Diane D.
Vydáno 2021Text -
17
Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment Autor Guo, Cen, Yu, Yanke, Chakrabarti, Jayeta, Piha‐Paul, Sarina A., Moroose, Rebecca, Plotka, Anna, Shi, Haihong, Durairaj, Chandrasekar, Wang, Diane D., Wainberg, Zev A.
Vydáno 2022Text -
18
Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy Autor Wheler, J. J., Falchook, G. S., Tsimberidou, A. M., Hong, D. S., Naing, A., Piha-Paul, S. A., Chen, S. S., Fu, S., Stephen, B., Fok, J. Y., Janku, F., Kurzrock, R.
Vydáno 2013Text -
19
Combining Erlotinib and Cetuximab is Associated with Activity in Patients with Non Small Cell Lung Cancer (including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutat... Autor Wheler, Jennifer J., Tsimberidou, Apostolia M., Falchook, Gerald S., Zinner, Ralph G., Hong, David S., Fok, Jansina Y., Fu, Siqing, Piha-Paul, Sarina A., Naing, Aung, Kurzrock, Razelle
Vydáno 2013Text -
20
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer Autor Meric-Bernstam, Funda, Johnson, Amber M., Dumbrava, Ecaterina E. Ileana, Raghav, Kanwal P., Balaji, Kavitha, Bhatt, Michelle, Murthy, Rashmi K., Rodon, Jordi, Piha-Paul, Sarina A.
Vydáno 2018Text
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Oncology
Cancer
Biology
Cancer research
Clinical trial
Gastroenterology
Gene
Immunotherapy
Adverse effect
Genetics
Pembrolizumab
Biochemistry
Pharmacology
Colorectal cancer
Pathology
Response Evaluation Criteria in Solid Tumors
Surgery
Breast cancer
Clinical endpoint
Chemotherapy
Mutation
PI3K/AKT/mTOR pathway
Phases of clinical research
Bioinformatics
KRAS
Tolerability
Confidence interval
Signal transduction